About
Portfolio
News
Contact
Contact us
Join Us
News
News
2023.08.16
Wugen Begins First-in-Human Phase 1 Clinical Trial of WU-NK-101, its Lead Allogeneic M...
2023.08.16
Wugen Begins First-in-Human Phase 1 Clinical Trial of WU-NK-101, its Lead Allogeneic M...
view more
2023.06.26
Shionogi Further Extends Infectious Disease Innovation Platform with Planned Acquisition of...
2023.06.26
Shionogi Further Extends Infectious Disease Innovation Platform with Planned Acquisition of...
view more
2023.05.24
Dr. Ramon Gonzalez Appointed Chief Scientific Officer at MojiaBio
2023.05.24
Dr. Ramon Gonzalez Appointed Chief Scientific Officer at MojiaBio
view more
2023.05.11
Wugen Appoints Industry Leader Mark Alles as Chair of the Board of Directors
2023.05.11
Wugen Appoints Industry Leader Mark Alles as Chair of the Board of Directors
view more
2023.04.19
Wugen Presents New Preclinical Data Reinforcing Anti-Tumor Functionality of WU-NK-101 a...
2023.04.19
Wugen Presents New Preclinical Data Reinforcing Anti-Tumor Functionality of WU-NK-101 a...
view more
2023.03.25
Neurelis announces first healthy subjects dosed in investigational study of nrl-1049, a rho kinase ...
2023.03.25
Neurelis announces first healthy subjects dosed in investigational study of nrl-1049, a rho kinase ...
view more
1
2
3
4
5
6
7
8
9
10
11
2023.08.16
